COG AEWS1221: Randomized phase 3 trial evaluating the addition of the IGF-1R monoclonal antibody ganitumab (AMG 479, NSC# 120449) to multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma,
Role: Investigator,
Children Oncology Group,
(01/2025 - 01/2026)
Status: Approved
Children’s Oncology Group (COG) protocol AOST06B1 – collecting and banking osteosarcoma specimens,
Role: Investigator,
Children Oncology Group,
(05/2023 - 05/2024)
Status: Completed
COG - AOST0331, A randomized trial of the European and American Osteosarcoma Study Group to optimize treatment strategies for resectable osteosarcoma based on histologic response to pre-operative chemotherapy (EURAMOS 1),
Role: Investigator,
Children Oncology Group,
(07/2011 - 07/2012)
Status: Completed
Internal
A phase II study of preoperative proton therapy in soft tissue sarcomas of the extremities and body wall,
Role: Investigator,
LLU Dept. of Radiation Medicine,
(05/2022 - 05/2023)
Status: Completed
Opioid consumption of pediatric with bone sarcomas,
Role: PI,
LLU Dept. of Orthopedic Surgery,
(03/2019 - 06/2022)
Status: Completed
Differential subchondral perfusion mapping using indocyanin green laser angiography,
Role: PI,
LLU Dept. of Orthopedic Surgery,
(03/2017 - 03/2018)
Status: Completed
The effect of local anesthetics and non-steroidal anti-inflammatory medications on sarcoma,
Role: PD/PI,
LLU School of Medicine,
(01/2016 - 02/2021)
Status: Closed
LLU Cancer Center biospecimen laboratory - specimens collection protocol,
Role: Investigator,
LLU Cancer Institute,
(09/2024 - 09/2025)
Status: Approved
Non-Profit Organization
Simple bone cyst in kids (SBoCK),
Role: Investigator,
Hospital for Sick Children Foundation,
(06/2024 - 06/2025)
Status: Approved